{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=FLOVENT+500mcg", "query": { "intervention": "FLOVENT 500mcg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-11T22:08:53.324Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00927758", "title": "Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate/salmeterol (Flu/Sal) : 100mcg/50mcg, 250mcg/50mcg,500mcg/50 mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sandoz", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 105, "start_date": "2009-06", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2017-03-29", "last_synced_at": "2026-09-11T22:08:53.324Z", "location_count": 3, "location_summary": "Gainesville, Florida • Iowa City, Iowa • Madison, Wisconsin", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00927758" }, { "nct_id": "NCT00358358", "title": "Chronic Obstructive Pulmonary Disease Endpoints Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone Propionate/Salmeterol 500/50mcg combination", "type": "DRUG" }, { "name": "Fluticasone Propionate 500mcg", "type": "DRUG" }, { "name": "Salmeterol 50mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 163, "start_date": "2006-03", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2017-01-20", "last_synced_at": "2026-09-11T22:08:53.324Z", "location_count": 4, "location_summary": "Absecon, New Jersey • Charleston, South Carolina • Greenville, South Carolina + 1 more", "locations": [ { "city": "Absecon", "state": "New Jersey" }, { "city": "Charleston", "state": "South Carolina" }, { "city": "Greenville", "state": "South Carolina" }, { "city": "Spartanburg", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00358358" }, { "nct_id": "NCT00920543", "title": "GSK BHR Study (Sont)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "FP 100mcg", "type": "DRUG" }, { "name": "FP 500mcg", "type": "DRUG" }, { "name": "FP 250mcg", "type": "DRUG" }, { "name": "FSC 100/50mcg", "type": "DRUG" }, { "name": "FSC 250/50mcg", "type": "DRUG" }, { "name": "FSC 500/50mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 464, "start_date": "2003-02", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2016-09-01", "last_synced_at": "2026-09-11T22:08:53.324Z", "location_count": 52, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Carmichael", "state": "California" }, { "city": "Palmdale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00920543" }, { "nct_id": "NCT01966692", "title": "Sensitivity of Pharmacokinetics to Differences in Aerodynamic Particle Size Distribution", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Propionate Formulation 1", "type": "DRUG" }, { "name": "Fluticasone Propionate Formulation 2", "type": "DRUG" }, { "name": "Fluticasone Propionate Formulation 3*", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 24, "start_date": "2016-11", "completion_date": "2018-01-20", "has_results": true, "last_update_posted_date": "2024-05-06", "last_synced_at": "2026-09-11T22:08:53.324Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01966692" }, { "nct_id": "NCT00576069", "title": "Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Asthma" ], "interventions": [ { "name": "budesonide/formoterol", "type": "DRUG" }, { "name": "fluticasone/salmeterol", "type": "DRUG" }, { "name": "mometasone/formoterol", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gelb, Arthur F., M.D.", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "10 Years to 95 Years" }, "enrollment_count": 60, "start_date": "2007-10-25", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2023-10-26", "last_synced_at": "2026-09-11T22:08:53.324Z", "location_count": 1, "location_summary": "Lakewood, California", "locations": [ { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00576069" }, { "nct_id": "NCT01475721", "title": "SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "ADVAIR 100/50mcg", "type": "DRUG" }, { "name": "ADVAIR 250/50mcg", "type": "DRUG" }, { "name": "ADVAIR 500/50mcg", "type": "DRUG" }, { "name": "FLOVENT 100mcg", "type": "DRUG" }, { "name": "FLOVENT 250mcg", "type": "DRUG" }, { "name": "FLOVENT 500mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 11751, "start_date": "2011-11-18", "completion_date": "2015-06-23", "has_results": true, "last_update_posted_date": "2018-08-06", "last_synced_at": "2026-09-11T22:08:53.324Z", "location_count": 350, "location_summary": "Athens, Alabama • Birmingham, Alabama • Florence, Alabama + 273 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01475721" }, { "nct_id": "NCT01324362", "title": "GSK BHR Study (Sont - Second Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "FP 100mcg", "type": "DRUG" }, { "name": "FP 250mcg", "type": "DRUG" }, { "name": "FP 500mcg", "type": "DRUG" }, { "name": "FSC 100/50mcg", "type": "DRUG" }, { "name": "FSC 250/50mcg", "type": "DRUG" }, { "name": "FSC500/50mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 446, "start_date": "2003-01", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2016-09-01", "last_synced_at": "2026-09-11T22:08:53.324Z", "location_count": 51, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Glendale, Arizona + 43 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01324362" }, { "nct_id": "NCT00603746", "title": "A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "GW685698X", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 627, "start_date": "2007-12-01", "completion_date": "2008-09-20", "has_results": true, "last_update_posted_date": "2017-09-15", "last_synced_at": "2026-09-11T22:08:53.324Z", "location_count": 94, "location_summary": "Phoenix, Arizona • Fort Smith, Arkansas • Little Rock, Arkansas + 82 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "Granada Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00603746" }, { "nct_id": "NCT01225913", "title": "Mechanism(s) of Airflow Limitation During Exacerbation of Asthma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone/salmeterol in all asthmatics", "type": "DRUG" }, { "name": "budesonide/formoterol or fluticasone/salmeterol in all asthmatics", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gelb, Arthur F., M.D.", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "10 Years to 80 Years" }, "enrollment_count": 50, "start_date": "2007-10", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2023-10-26", "last_synced_at": "2026-09-11T22:08:53.324Z", "location_count": 1, "location_summary": "Lakewood, California", "locations": [ { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01225913" }, { "nct_id": "NCT00268216", "title": "Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Salmeterol 50mcg/ Fluticasone Propionate 500mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 6228, "start_date": "2000-09", "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2017-01-20", "last_synced_at": "2026-09-11T22:08:53.324Z", "location_count": 190, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Mobile, Alabama + 152 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00268216" } ] }